Advertisement

Topics

Companies Related to "Norwest Venture Partners" [Most Relevant Company Matches] - Page: 3 RSS

11:47 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Norwest Venture Partners" found in our extensive corporate database of over 50,000 company records.

Showing "Norwest Venture Partners" Companies 51–75 of 3,100+

Relevant

Relypsa Inc.

Relypsa, Inc. is a, clinical-stage biopharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases. Relypsa's lead product candidate is RLY5016, a non-absorbed potassium binder for the treatment of hyperkalemia. Relypsa is dedicated to the discovery of add...


Moximed, Inc.

Moximed® Inc is dedicated to improving the standard of care for patients with osteoarthritis. OA, the most common form of arthritis, leads to a breakdown of the joint’s cartilage and often results in joint pain and loss of motion. OA commonly affects the knees, hips, hands, or back. Moximed is initially focused on developing minimally invasive, joi...

Moximed Inc

Moximed Inc is dedicated to improving the standard of care for patients with osteoarthritis. OA, the most common form of arthritis, leads to a breakdown of the joint’s cartilage and often results in joint pain and loss of motion. OA commonly affects the knees, hips, hands, or back. Moximed is initially focused on developing minimally invasive, joint p...


Enterprise Partner

Enterprise Partners was founded in 1985 and is one of the oldest venture firms in Southern California. To date, we’ve helped build over 155 companies and we’re busy investing our 6th fund. We are pleased to say that we have put over $1.1 billion to work for those companies, making us the largest venture firm headquartered in Southern California.

NLV Partners

New Leaf Venture Partners is a leader in healthcare technology venture investing. Our investment professionals bring a unique blend of technological, clinical, and operational experience to our investments. We work closely with our entrepreneurs to help build successful portfolio companies. We focus primarily on later stage biopharmaceutical products, earl...

ProPharma Partners (UK)

ProPharma Partners, Inc. assists biotechnology and pharmaceutical clients with corporate partnering, in-licensing, out-licensing, mergers or acquisitions, drug development, clinical planning, new venture strategic planning, technology assessment and valuations.

Presto Services Inc.

Presto was founded in 2004 to help families and friends stay better connected by making it easier for them to share digital content. Presto's first consumer solution launched in November 2006: the Presto Printing Mailbox coupled with the Presto Mail service, which delivers email, photos, PDF documents and ad-free subscription content. Presto's publishing partners include Meredith Corporation and T...

Coferon, Inc.

Coferon is an angel and venture-backed company with a syndicate led by Hatteras Venture Partners and Ascent Biomedical Venture Partners formed to exploit the novel and potentially ground breaking Coferon platform. Coferon's approach bridges the gap between small molecule drugs - which can be orally delivered and hit targets both in and outside the cell, bu...

Arch Oncology, Inc.

Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of best-in-class antibody therapies for the treatment of patients with cancer. The Company’s next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative...

Oraya Therapeutics, Inc.

Oraya Therapeutics, Inc. is a privately-held company developing innovative and non-invasive therapies for diseases of the eye. The company was founded in 2006. Its investors include Essex Woodlands Health Ventures, Domain Associates, Scale Venture Partners, and Synergy Life Science Partners. The company's first commercial application, the IRay system, is c...

Delta Partners

Delta Partners is a venture capital firm investing Ireland and the United Kingdom. It was established in 1994 and now has €130 million under management. The firm has a strong focus on investing in early stage technology companies, and the team has made over 50 investments in the following sectors:

Cerebrotech Medical Systems

Cerebrotech Medical Systems, Inc., is a venture capital-backed company dedicated to designing neurotechnology solutions to improve the care of brain-injured patients worldwide. The company is developing a portable, noninvasive neuro-monitoring device that allows for earlier detection of potentially life-threatening conditions such as large vessel occlusion...

Cerebrotech Medical Systems, Inc.

Cerebrotech Medical Systems, Inc., is a venture capital-backed company dedicated to designing neurotechnology solutions to improve the care of brain-injured patients worldwide. The company is developing a portable, noninvasive neuro-monitoring device that allows for earlier detection of potentially life-threatening conditions such as large vessel occlusion...

OncoMed Pharmaceuticals, Inc.

OncoMed is a clinical development-stage biopharmaceutical company focused on discovering and developing first-in-class monoclonal antibody therapeutics targeting cancer stem cells, or CSCs. Our approach has been to target CSCs, which are the subpopulation of cells in a tumor responsible for driving growth and metastasis of the tumor. CSCs, also known as tumor-initiating cells, exhibit certain pr...

Marquette Venture Partners

Marquette Venture Partners was founded in 1987 to make equity investments in early and growth stage companies. The firm has a long term investment focus and has emphasized investments in the healthcare, information technology and consumer services industries. Our mission is to partner with talented management teams who share with investors in the financial rewards of ownership resulting from their...

Hatchtech

Hatchtech Pty Ltd is a venture-backed specialty pharmaceutical product company that is developing technology for the control of invertebrate pests. The Company’s investors include, GBS Venture Partners, Queensland Biotechnology Fund, Uniseed, University of Melbourne Endowment Trust, AustralianSuper, and OneVentures Innovation Fund. The OneVentures Inn...

Propharma Partners Incorporated USA

ProPharma Partners, Inc. assists biotechnology and pharmaceutical clients with corporate partnering, in-licensing, out-licensing, mergers or acquisitions, drug development, clinical planning, new venture strategic planning, technology assessment and valuations, and financing of early and mid-stage companies.

BridgePoint Medical, Inc.

BridgePoint Medical, Inc. is a privately held company established in 2006 to design, develop and commercialize new technologies and techniques to treat challenging coronary artery disease. Investors include New Enterprise Associates, Polaris Venture Partners, Foundation Medical Partners and Michael Berman.

Seventure Partners

Seventure Partners is a leading venture capital firm in Europe. Since 1997, Seventure has invested in innovative businesses with high growth potential in digital technologies in France and Germany and in the life sciences field across Europe and North America, with currently over €500m in assets under management as of the end of 2014.

EuclidSR Partners

Successful venture investing combines two essential components: finding opportunities with significant growth potential and helping to deliver on that potential. It requires a committed approach by experienced investors, not just to building returns but to building companies. Successful investors - armed with deep knowledge of their industries - commit time and focus in addition to capital.EuclidS...

Cerulean Pharma Inc.

Cerulean Pharma Inc. is a privately-held biopharmaceutical company focused on the development of novel nanotechnology-based therapeutics in the areas of oncology, cardiovascular, autoimmune and inflammatory diseases. The Company has assembled a world-class management team, board of directors and scientific advisory board that collectively have a significan...

Solace Therapeutics Inc.

Solace Therapeutics is dedicated to developing innovative, non-surgical and clinically effective devices that address unmet needs in lower urinary tract symptoms (LUTS). Our initial focus is on improving the quality of life for women whose daily life is disrupted by their incontinence. The Company’s venture capital investors include New Enterprise Ass...

Relypsa, Inc.

Relypsa, Inc. is a clinical-stage biopharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases. Relypsa's lead product candidate is RLY5016, a non-absorbed potassium binder for the treatment of hyperkalemia. Relypsa is pursuing the discovery of addition...

Venture Valuation Inc.

Venture Valuation was founded in spring 1999 based on research work by the founder and CEO, Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne (EPFL). Since the very beginning, Novartis Venture Fund (part of the worldwide life science company Novartis International AG) is a main customer for which Venture Valuation carries out all external ...

Pritzker Group Private Capital

Pritzker Group, led by Tony and J.B. Pritzker, has three principal investment teams: Private Capital, which acquires and operates leading North America-based companies; Venture Capital, which is the largest technology venture investor based in the Midwest; and Asset Management, which partners with top-performing investment managers acrossÂ...


More From BioPortfolio on "Norwest Venture Partners"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks